We are live on ! Find out more
AKYA

Akoya BioSciences
AKYA

Delisted

AKYA was delisted on the 7th of July, 2025.

Back to rankings

60 hedge funds and large institutions have $189M invested in Akoya BioSciences in 2021 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27.12% more ownership

Funds ownership: 0% → 27.12% (+27%)

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
+$46.3M
2
HEC
Hudson Executive Capital
New York
+$22.1M
3
Capital World Investors
Capital World Investors
California
+$14.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.3M
5
BlackRock
BlackRock
New York
+$9.12M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BOTOTLSJU
1
Board of Trustees of The Leland Stanford Junior University
California
$43.4M +$46.3M +2,243,775 New
HEC
2
Hudson Executive Capital
New York
$20.7M +$22.1M +1,069,984 New
Capital World Investors
3
Capital World Investors
California
$13.5M +$14.5M +700,000 New
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$9.68M +$10.3M +500,644 New
BlackRock
5
BlackRock
New York
$8.54M +$9.12M +441,785 New
VA
6
VR Adviser
New York
$7.74M +$8.26M +400,000 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$7.7M +$8.22M +398,300 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$6.67M +$7.12M +344,935 New
Franklin Resources
9
Franklin Resources
California
$6.18M +$6.6M +319,600 New
American Century Companies
10
American Century Companies
Missouri
$5.91M +$6.31M +305,546 New
PA
11
Perceptive Advisors
New York
$5.8M +$6.19M +300,000 New
FAM
12
Fred Alger Management
New York
$5.38M +$5.75M +278,326 New
Lord, Abbett & Co
13
Lord, Abbett & Co
New Jersey
$5.1M +$5.44M +263,544 New
PVI
14
Pura Vida Investments
New York
$4.63M +$4.95M +239,566 New
Jennison Associates
15
Jennison Associates
New York
$4.58M +$4.89M +236,797 New
Wells Fargo
16
Wells Fargo
California
$4.27M +$4.56M +220,777 New
OCM
17
Osterweis Capital Management
California
$2.72M +$2.9M +140,688 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.43M +$2.6M +125,698 New
Morgan Stanley
19
Morgan Stanley
New York
$2.14M +$2.28M +110,502 New
Millennium Management
20
Millennium Management
New York
$2.07M +$2.21M +106,872 New
RCM
21
Ratan Capital Management
Florida
$1.93M +$2.06M +100,000 New
RI
22
RTW Investments
New York
$1.93M +$2.06M +100,000 New
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$1.62M +$1.73M +83,619 New
State Street
24
State Street
Massachusetts
$1.58M +$1.69M +81,780 New
Northern Trust
25
Northern Trust
Illinois
$1.51M +$1.61M +78,100 New
1
2 3

AKYA Hedge Fund Activity: Q2 2021 in Review

60 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2021, worth a combined $189M.

Buyers outnumbered sellers: 60 funds opened new AKYA positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $46.3M.

  • 60 institutional investors held Akoya BioSciences (AKYA) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $189M of Akoya BioSciences stock for Q2 2021.
  • 60 funds opened new Akoya BioSciences positions in Q2 2021 and 0 closed out, a net change of +60 holders.
  • The largest Akoya BioSciences buyer in Q2 2021 was Board of Trustees of The Leland Stanford Junior University, an estimated $46.3M added.

Based on aggregated 13F filings for Q2 2021.